Press release
Leading Growth Driver in the PEGylated Proteins Market in 2025: Rising Prevalence Of Lifestyle Diseases Is Driving Growth Of The PEGylated Proteins Market Driver's Influence
PEGylated Proteins Market
The market size for pegylated proteins has seen an expedited expansion recently. It is projected to balloon from $1.47 billion in 2024 to $1.68 billion in 2025, showing a compound annual growth rate (CAGR) of 14.1%. This upswing in the historical period was influenced by several key factors like enhanced therapeutic effectiveness, an increase in the elderly population, a rising demand for protracted action formulations, improved safety profiles of the drugs, and expanding utilization areas like targeted drug delivery systems.
The market for pegylated proteins is predicted to experience harried expansion in the following years, escalating to $2.8 billion in 2029 with a compound annual growth rate (CAGR) of 13.7%. Factors contributing to this projected growth encompass increased funding in rare disease research, swift advancement in the biopharmaceutical sector, the progression of precision medicine, growing competition due to biosimilar versions of biologic drugs, and application of novel market entry strategies. Key trends anticipated over the forecast period consist of the incorporation of digital health technology, emerging pegylation technology, personalized formulations for precision medication, emphasis on combination therapies, and a transition to patient-focused healthcare practices.
What Is Stimulating Growth in the PEGylated Proteins Market?
The surge in lifestyle-related diseases is anticipated to stimulate the expansion of the PEGylated proteins market. Lifestyle diseases are health issues primarily induced by unhealthy behaviors and lifestyle preferences such as poor nutrition, insufficient physical exercise, and smoking. The rise in lifestyle diseases can be attributed to a mix of factors such as decreased physical activity, diets rich in processed food, and elevated stress levels. PEGylated proteins are used in the treatment of these diseases by improving the performance, longevity, and targeted delivery of therapeutics for conditions such as cardiovascular disorders, diabetes, and certain types of cancer. For example, as per the Office for Health Improvement and Disparities, a government agency in the UK, it was reported in May 2024 that an approximated 64.0% of adults aged 18 and over in England were considered as overweight or obese in 2022 to 2023, a mild increase from 63.8% in 2021 to 2022. As a result, the upward trend in the rate of lifestyle diseases is fuelling the development of the PEGylated proteins market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16145&type=smp
Which Key Market Leaders Are Driving PEGylated Proteins Industry Growth?
Major companies operating in the PEGylated proteins market are Merck & Co. Inc., Bayer AG, Bristol Myers Squibb Company, AstraZeneca PLC, Roche Holding AG, Gilead Sciences Inc., Novo Nordisk A/S, Evonik Industries AG, Viatris Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Lonza Group Ltd., Jazz Pharmaceuticals plc, Ipsen Pharma, Kyowa Kirin Co. Ltd., WuXi Biologics, BioMarin Pharmaceutical Inc., Ligand Pharmaceuticals Incorporated, Zydus Cadila, Enzon Pharmaceuticals Inc.
What Are the Emerging Trends in the PEGylated Proteins Industry?
Leading players in the PEGylated protein market are striving to gain a competitive advantage by developing novel products like PEGylation reagents. These are chemical substances that bind polyethylene glycol (PEG) chains to biomolecules, thereby modifying their properties for various biomedical uses. For example, Creative Enzymes, an American firm specializing in food additives and enzymes, introduced DSPE-PEG-Maleimide for targeted drug delivery in May 2023. DSPE-PEG-Maleimide (DSPE-PEG-MAL), a linear heterobifunctional PEGylation reagent, incorporates DSPE phospholipids and maleimide. This versatile self-assembly reagent can be utilised to create PEGylated liposomes or micelles and additionally offers thiol or cysteine reactive maleimide groups. It is commonly used for targeted drug delivery.
What Are the Main Segments in the PEGylated Proteins Market?
The pegylated proteins market covered in this report is segmented -
1) By Product: Consumable And Services, PEGylation Kits And Reagents, Monofunctional Linear PEGs, Bifunctional PEGs, Services, Other Products
2) By Protein Type: Colony Stimulating Factors, Interferons, Erythropoietin, Recombinant Factor VII, Other Protein Types
3) By Application: Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, Other Applications
4) By End User: Pharmaceuticals, Biotechnology Companies, Contract Research Organizations, Academic Research Institutes
Subsegments:
1) By Consumable And Services: Consumables, Services (Contract Services, PEGylation Services)
2) By PEGylation Kits And Reagents: PEGylation Kits, Reagents
3) By Monofunctional Linear PEGs: Monofunctional PEGs For Protein Modification
4) By Bifunctional PEGs: Bifunctional PEGs For Protein Modification
5) By Other Products: Conjugates, PEGylated Drugs And Therapeutics
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pegylated-proteins-global-market-report
Which Geographic Area Leads the PEGylated Proteins Market?
North America was the largest region in the PEGylated Proteins market in 2024. The regions covered in the PEGylated proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The PEGylated Proteins Global Market Report?
- Market Size Analysis: Analyze the PEGylated Proteins Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the PEGylated Proteins Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall PEGylated Proteins Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the PEGylated Proteins Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16145
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the PEGylated Proteins Market in 2025: Rising Prevalence Of Lifestyle Diseases Is Driving Growth Of The PEGylated Proteins Market Driver's Influence here
News-ID: 3866046 • Views: …
More Releases from The Business Research Company
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth?
In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)…
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025?
In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,…
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025?
The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate…
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025?
The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.…
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…
